Commonwealth Bank of is scheduled to report its 1H22 result on 9 February 2022. Forecasting 1H22 cash earnings of $4.3bn with the FY22 interim dividend of $1.74 per share.
We remain underweight Australian banks.
CIM:ASX is likely to see improved earnings in FY22 and we expect to soon see a recovery in the share price.
CIMIC is a high-risk counter-trend investment with the prospect of a multi-year recovery, once earnings hit an inflection point.
| Upcoming key dates | |
| Full year financial results | 10 February 2022 |
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
CIM:ASX is likely to see improved earnings in FY22 and we expect to soon see a recovery in the share price.
CIMIC is a high-risk counter-trend investment with the prospect of a multi-year recovery, once earnings hit an inflection point.
Gold Road Resources remains our preferred gold exposure.
SLF:AXW is under Algo Engine buy conditions and is a current holding in our ASX ETF model portfolio.
SLF, LLC and GMG are our preferred property exposures.
Bega recently provided a trading update, with FY22 underlying EBITDA expected to be in the range of
A$195-215mn.
Earnings have been impacted by supply chain-related disruptions, with some offset by the full-year contribution of the Lion Dairy & Drinks acquisition and related cost synergies. FY23 earnings should reaccelerate and recent shareholder support from Andrew Forrest suggests the current price range is a good opportunity to build a position.
2/2Update:
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Level 17 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453
Or start a free thirty day trial for our full service, which includes our ASX Research.